Pharmacy is currently facing supply disruption for Pantoprazole 40mg Injection. The manufacturer is unable to predict when stocks will resume.Suggested alternative: Esomeprazole 40mg Injection
23-Dec-2022 (NO. SP PPUM: 577/2022)
Medication Supply Disruption: Normal Immunoglobulin 2.5g Injection
Pharmacy is currently facing supply disruption for Normal Immunoglobulin 2.5g Injection whilestocks are expected to resumein January 2023.Pharmacy shall be restricting supply to patients with Immune Thrombocytopenic Purpura (ITP), Kawasaki Disease and critical cases only.
Pharmacy is currently facing supply disruption for Cetirizine 10mg Tablet. The manufacturer is unable to predict when stocks will resume.Suggested alternative: Loratadine 10mg Tablet
Pharmacy is currently facing supply disruption for Co-Amoxiclav 1200mg Injection while new stocks are expected to arrive end of December 2022.Suggested alternative: Ampicillin 1000mg Sulbactam 500mg Injection
Pharmacy is currently facing supply disruption for Diphenhydramine 14mg/5mL Syrup while new stocks are expected to arrive end of December 2022.Suggested alternative: Ammonium Ipecacuanha Mixture
16-Nov-2022 (NO. SP PPUM: 500/2022)
Change in Strength: Brimonidine Ophthalmic Solution
❗️New Strength:-Previously: Brimonidine 0.15% Ophthalmic Solution❗️Now: Brimonidine 0.1% Ophthalmic Solution There new formulation will have the same effectiveness as the older formulation and hence no dosage adjustment is needed.
Pharmacy is currently facing supply disruption for Sodium Chloride 0.9% Injection (10mL) while new stocks are expected to arrive mid of November 2022.Suggested alternative: Sodium Chloride 0.9% Injection (100mL)
The supplier updated that the supply disruption is due to the delay in shipment from manufacturer and the existing stocks in our Pharmacy have been depleted.New stocks are expected to arrive end of March 2023.
The supplier updated that the supply disruption is due to the delay in shipment from manufacturer and the existing stocks in our Pharmacy have been depleted.New stocks are expected to arrive end of March 2023.
The supplier updated that the supply disruption is due to raw material issues and the existing stocks in our Pharmacy have been depleted.New stocks are expected to arrive end ofOctober 2022.
Supplier updated that the new stocks are expected to arrive in four to six weeks time and the existing stocks in the Pharmacy are currently at the minimal level.Existing stocks will be reserved for patients with a positive culture for Multidrug Resistant Acinetobacter baumannii only.Suggested alternative: Co-Amoxiclav 1200mg Injection
As the manufacturer is facing raw material issues, the manufacturer is unable to predict when stocks will resume.The existing stocks in our Pharmacy have been depleted.
05-Sep-2022 (NO. SP PPUM: 366/2022)
Deletion of Drug from Formulary: Acarbose 100mg Tablet
The Acarbose 100mg Tablet will be replaced with Empagliflozin 25mg Tablet in the UMMC Formulary.
Supply disruption is due to the delay in shipment from manufacturer.
24-Aug-2022 (NO. SP PPUM: 348/2022)
Oral Prednisolone Dose Changes for Imaging with Contrast Media
❗️New Dosage:-Adults: 40mg per dose, to take 12 hours and 2 hours before imaging.Pediatrics: 1.25mg/kg per dose (maximum 40mg), to take 12 hours and 2 hours before imaging.
Supply disruption is due to the supply interruption of raw materials by the supplier.New stocks are expected to arrive early September 2022.Suggested alternative: Betamethasone Valerate 0.02% Cream or Hydrocortisone 1% Cream
02-Aug-2022 (NO. SP PPUM: 326/2022)
Medication Changes in Code Blue Box: Ephedrine Injection to Phenylephrine Injection
Referring to the previous circular NO. SP PPUM: 140/2022 regarding Ephedrine 30mg/1mL Injection's supply disruption, the existing stocks in the Pharmacy have been depleted.All Ephedrine 30mg/1mL Injections in the Code Blue Box will be temporarily replaced with Phenylephrine 10mg/1mL Injection until the supply for Ephedrine Injection resumes.
New stocks are expected to arrive in two to three weeks time and the existing stocks in the Pharmacy are currently at the minimal level.Existing stocks will be reserved for patients with a positive culture for Multidrug Resistant Acinetobacter baumannii.Suggested alternative: Co-Amoxiclav 1200mg Injection
New stocks are expected to arrive in two to three weeks time and the existing stocks in the Pharmacy are currently at the minimal level.Ward supply will be ceased until the Pharmacy has received new stocks.Suggested alternative: Metoclopromide 10mg Tablet or Prochlorperazine 12.5mg Injection
05-Jul-2022 (NO. SP PPUM: 278/2022)
New Warning, Precaution and Dose Modification Guidance: Alectinib 150mg Hard Capsule
This circular is to share the latest management of Haemolytic Anaemia by Roche Malaysia.Kindly refer to the email for details.
New stocks are expected to arrive in two weeks time and the existing stocks in the Pharmacy are currently at the minimal level.Existing stocks will be reserved for patients with Active Upper Gastrointestinal Bleeding only.Suggested alternative: Ranitidine 50mg Injection or Omeprazole 20mg Capsule
Supply disruption is due to global shortage and the existing stocks for Leuprorelin 11.25mg Depot Injection had depleted.Doctors are suggested to consider using Leuprorelin 3.75mg Depot Injection for the time being whilst awaiting the procurement of Triptorelin 11.25mg Injection.
17-Jun-2022 (NO. SP PPUM: 250/2022)
Medication Supply Disruption: Amitriptyline 10mg Tablet and Amitriptyline 25mg Tablet
New stocks are predicted to arrive in Jul-2022.
16-Jun-2022 (NO. SP PPUM: 247/2022)
Medication Supply Resume: Human Albumin 20% Injection
We are pleased to inform that Human Albumin 20% Injection is available and the existing stocks for Human Albumin 25% Injection had depleted.All new prescriptions and ongoing prescriptions for Human Albumin 25% Injection will need to be changed to Human Albumin 20% Injection.
Fluticasone 125mg Inhaler will be temporarily replaced with Budesonide 200mcg Inhaler effective immediately. 1 puff of Fluticasone 125mcg Inhaler is equivalent to 1 puff of Budesonide 200mcg Inhaler This conversion was agreed with the Respiratory Medicine Specialist and will be done automatically for prescription refills.
03-Jun-2022 (NO. SP PPUM: 231/2022)
Medication Supply Disruption: Mepivacaine 2% with Adrenaline 1:100,000 Injection
Suggested alternative: Lidocaine Injection.
03-Jun-2022 (NO. SP PPUM: 229/2022)
Medication Supply Disruption: Human Albumin 20% Injection
Human Albumin 20% Injection will be replaced with Human Albumin 25% Injection temporarily due to supply disruption. Human Albumin 20% Injection: 10g/50mLHuman Albumin 25% Injection: 12.5g/50mL All doctors and nurses must be aware that there will be changes in the dose calculation when prescribing or administering Human Albumin 25% Injection.Suggested dosage if 1g/kg/day is required:- Human Albumin 20% Injection: 5mL/kg/dayHuman Albumin 25% Injection: 4mL/kg/day
01-Jun-2022 (NO. SP PPUM: 226/2022)
Deletion of Drug from Formulary: Neurobion Tablet
The Neurobion Tablet will be replaced with Bionerv Tablet effective immediately.
Supply disruption is due to supplier issues.The alternative supply is predicted to arrive in stages by May-2022.Stocks in the Pharmacy are at a minimum level.Suggested alternative: Noradrenaline 4mg/4mL Injection
07-Apr-2022 (NO. SP PPUM: 126/2022)
Medication Supply Disruption: Normal Immunoglobulin 2.5g Injection (Updated)
With reference to the previous circular (No. SP PPUM: 038/2022), we are still facing supply disruption and the stocks in the Pharmacy are at a very critical level.Doctors are suggested to postpone IVIG treatment for elective cases as Pharmacy shall be restricting supply to patients with Immune Thrombocytopenic Purpura (ITP), Kawasaki Disease and critical cases only.
Supply disruption is due to temporary out of stock.Supplier is unable to predict when the stocks will resume.Suggested alternative: to add Amoxicillin 500mg Capsules to Amoxicillin 500mg Clavulanate 125mg Tablets
10-Feb-2022 (NO. SP PPUM: 052/2022)
Deletion of Drug from Formulary: Etomidate 20mg/10mL Injection
Supply disruption is due to manufacturing issues.Supplier is unable to predict when the stocks will resume and hence it was decided that the Pharmacy Department will permanently stop the procurement of this drug.
31-Jan-2022 (NO. SP PPUM: 038/2022)
Medication Supply Disruption: Normal Immunoglobulin 2.5g Injection
Supply disruption is due to increased global usage.Supplier predicts that limited stocks will arrive in stages by Feb-2022, however there is no confirmation when stocks will be replenished.Pharmacy shall be restricting supply to patients with Immune Thrombocytopenic Purpura (ITP) and Kawasaki Disease only for the time being.
11-Jan-2022 (NO. SP PPUM: 012/2022)
Sennosides 7.5mg Tablet
In the midst of LPO (Local Purchase Order) process - will take time for its approval and subsequently its distribution to the Pharmacy Department.Suggested alternatives: Lactulose Solution, Bisacodyl 5mg Tablets
11-Jan-2022 (NO. SP PPUM: 011/2022)
Oestrogen (Conjugated) 0.625mg per G Vaginal Cream
Global shortage and no equivalent alternatives in the UMMC Formulary. Supplier predicts that stocks will resume by Feb-2022.